National Bank of Canada’s Amgen AMGN Stock Holding History

National Bank of Canada’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16M	Sell	455 -266	-37%	-$94.8K	0.01%	550
2025 Q4	$23.6M	Buy	+721	New	+$229K	0.02%	474
2025 Q3	–	Sell	-2,950	Closed	-$82.4M	–	2841
2025 Q2	$82.4M	Buy	+2,950	New	+$836K	0.08%	213
2024 Q4	–	Sell	-400	Closed	-$12.9M	–	2928
2024 Q3	$12.9M	Buy	+400	New	+$131K	0.01%	603
2024 Q1	–	Sell	-1,525	Closed	-$45.4M	–	2723
2023 Q4	$45.4M	Sell	1,525 -19	-1%	-$5.18K	0.07%	248
2023 Q3	$41.1M	Buy	+1,544	New	+$385K	0.06%	267
2022 Q3	–	Sell	-2,000	Closed	-$48.7M	–	2684
2022 Q2	$48.7M	Buy	+2,000	New	+$490K	0.22%	109

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

National Bank of Canada's AMGN Position: Q1 2026 in Review

National Bank of Canada reduced its Amgen (AMGN) stake by 38% in Q1 2026, selling an estimated $90.9M and leaving 420,993 shares worth $148M. The position accounts for 0.13% of the portfolio, ranked #135.

National Bank of Canada first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $346M in Q3 2025. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

National Bank of Canada held 420,993 shares of Amgen worth $148M as of Q1 2026.
National Bank of Canada sold 254,963 Amgen shares in Q1 2026, an estimated $90.9M.
Amgen made up 0.13% of National Bank of Canada's portfolio in Q1 2026, its #135 holding.
National Bank of Canada first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
National Bank of Canada's Amgen position peaked at $346M in Q3 2025.
3,137 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.